Patents by Inventor J. Gregory Koenig

J. Gregory Koenig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6824798
    Abstract: A method for preventing veisalgia wherein an extract is prepared from artichoke and sarsaparilla containing a complex of polyphenols, flavonoids, and phytosterols. According to a preferred method, a dose of 1260 mg of extract is orally administered to a person prior to consuming alcohol. Subsequent to alcohol consumption another 1260 mg of extract is administered. The 1260 mg dose is adequate for most persons, is not critical, and can be scaled to a person's weight. The method as described results in complete elimination of veisalgia in more than 80% of individuals. As an alternate embodiment, the first three 420 mg quantities can be administered during consumption of alcohol. A further alternate embodiment provides an additional dose of 420 mg every hour during drinking after a period exceeding 4 hours, followed by the final dose of three 420 mg quantities at the cessation of alcohol consumption.
    Type: Grant
    Filed: September 24, 2002
    Date of Patent: November 30, 2004
    Inventors: J. Gregory Koenig, Charles Cochran
  • Publication number: 20030077338
    Abstract: A method for preventing veisalgia wherein an extract is prepared from artichoke and sarsaparilla containing a complex of polyphenols, flavonoids, and phytosterols. According to a preferred method, a dose of 1260 mg of extract is orally administered to a person prior to consuming alcohol. Subsequent to alcohol consumption another 1260 mg of extract is administered. The 1260 mg dose is adequate for most persons, is not critical, and can be scaled to a person's weight. The method as described results in complete elimination of veisalgia in more than 80% of individuals. As an alternate embodiment, the first three 420 mg quantities can be administered during consumption of alcohol. A further alternate embodiment provides an additional dose of 420 mg every hour during drinking after a period exceeding 4 hours, followed by the final dose of three 420 mg quantities at the cessation of alcohol consumption.
    Type: Application
    Filed: September 24, 2002
    Publication date: April 24, 2003
    Inventors: J. Gregory Koenig, Charles Cochran